MedTrace Logo

Defining the Intestinal Microbiota in Premature Neonates

NCT01102738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 369

Last updated 2020-05-01

Study results available
· View outcomes & findings →

Summary

The investigators will collect daily faecal samples from premature (\<32 weeks) infants in the intensive care unit from the day of birth until they are discharged. By using newly developed molecular detection techniques the investigators aim to define more precisely than has ever previously been attempted, all the species of bacteria present in the faeces. This will enable comparison of the pre-morbid and post-morbid intestinal microbiota (all the bacteria in the gut) in premature neonates.

Conditions

  • Premature Intestinal Microbiota
  • Necrotizing Enterocolitis
  • Late Onset Bloodstream Infection

Sponsors & Collaborators

  • The Winnicott Foundation

    collaborator OTHER

  • National Heart and Lung Institute

    collaborator OTHER

  • Chelsea and Westminster NHS Foundation Trust

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • J Simon Kroll, MA BM FRCP · Imperial College London

Eligibility

Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31
Completion
2014-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102738 on ClinicalTrials.gov